Publications by authors named "E Longhi"

The use of fluorescent labels is the most common tool to visualize cells. However, the internalization of dye molecules often modifies the cell behavior. In this paper we demonstrate that it is possible to transiently label cells using a 3D scaffold, a hydrogel, covalently functionalized with luminescent cyclometalated iridium(III) complexes.

View Article and Find Full Text PDF

Extracellular vesicles (EV) have emerged as promising cell-free therapeutics in regenerative medicine. However, translating primary cell line-derived EV to clinical applications requires large-scale manufacturing and several challenges, such as replicative senescence, donor heterogeneity, and genetic instability. To address these limitations, we used a reprogramming approach to generate human induced pluripotent stem cells (hiPSC) from the young source of cord blood mesenchymal stem/stromal cells (CBMSC).

View Article and Find Full Text PDF

Intravenous immunoglobulin (IVIg) is a medical preparation used as replacement therapy for patients with immunodeficiencies. Over time, IVIg's anti-inflammatory and immunomodulatory effects have been recognized, which have led to the approval of this therapy in the treatment of various pathologies, such as Kawasaki disease, immune thrombocytopenia, and Guillain-Barré syndrome. There are numerous studies in the literature regarding the off-label use of IVIg in the treatment of autoimmune diseases (e.

View Article and Find Full Text PDF

Polyfunctional thiols are key contributors to wine aroma due to their extremely low odor thresholds, and their quantitative analysis remains challenging as a result of their ultratrace concentrations and high reactivity. This work presents the first method based on ultra-high-performance liquid chromatography (UHPLC) coupled to quadrupole Orbitrap high-resolution mass spectrometry (HRMS) in parallel reaction monitoring (PRM) mode for quantifying thiols at nanograms per liter (ng/L) levels in wine. Thiols in wine were derivatized using 4,4'-dithiodipyridine and isolated by liquid-liquid extraction.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organs, with recent studies highlighting the roles of oxidative stress and gut microbiota in its development.
  • Oxidative stress leads to harmful reactions in cells, while imbalances in gut bacteria (dysbiosis) are linked to SLE onset and worsening symptoms.
  • Intravenous immunoglobulins (IVIg) show promise as a treatment by reducing oxidative stress and restoring gut health, suggesting that targeting these factors could improve SLE management and outcomes.
View Article and Find Full Text PDF